STUDY QUESTION: What is the optimal timing for blastomere biopsy during the 8-cell stage, at which embryos will have the best implantation potential?
Introduction
Couples that carry mutations for severe genetic abnormalities are offered a genetic diagnostic procedure that is performed on the preimplantation embryos in order to diagnose the mutation-free embryos, and select them for transfer into the uterus (Gutierrez-Mateo et al., 2009) . This preimplantation genetic diagnosis (PGD) requires access to the DNA of the pre-implanted embryos. There are currently three main methods for that purpose: polar body biopsy, blastomere biopsy of cleavage-stage embryos or trophectoderm biopsy of blastocysts. Recently, trophectoderm biopsies have become very popular, especially for preimplantation genetic screening (PGS), and in some cases also for PGD of monogenic disorders. However, aspiration of blastomeres from cleavage-stage embryos remains the preferred biopsy method for PGD cycles (De Rycke et al., 2015; Cimadomo et al., 2016) .
Cleavage-stage biopsy for PGD is normally performed on Day 3 embryos with at least 6 blastomeres. It is an invasive procedure that involves loosening of the cell-cell adhesion and aspiration of single blastomeres from cleavage-stage embryos. The biopsied blastomeres are then taken for single-cell DNA analysis of the mutation causing the inherited disease. Embryo transfer following PGD requires the selection of embryo(s) with the highest implantation potential from among the genetically diagnosed mutation-free embryos. It is now feasible to combine PGS/preimplantation genetic testing (PGT) with PGD in order to detect both mutation-free and euploid embryos with the highest implantation potential. In most centers, the detection of the embryos with the highest implantation potential following PGD is still based upon evaluation of standard morphologic criteria (Ajduk and Zernicka-Goetz, 2013) . Studies that evaluated mouse embryos following blastomere biopsy, using standard morphological criteria, showed that the biopsy procedure resulted in an earlier compaction already at the 6-cell stage (Ugajin et al., 2010) , developmental delay (Tarin et al., 1992; Duncan et al., 2009) and reduced implantation potential (Scott et al., 2013) .
During the last 6 years, time-lapse microscopy (TLM) was introduced into the clinical IVF labs, providing a noninvasive method to analyze the full course of embryo development in real time without interfering with the optimal culture conditions (Meseguer et al., 2011) . Morphokinetic studies have already shown that morphokinetic evaluations can provide a more comprehensive analysis of developmental events than standard morphological evaluations for selecting topquality embryos with the highest implantation potential for transfer (reviewed in Pribenszky et al., 2017) . Other studies, however, have questioned the benefit of time-lapse systems over the traditional grading systems (reviewed in Chen et al., 2017) .
Recent studies, including ours, have shown that blastomere biopsy significantly delays the timing of compaction and the start of blastulation (Kirkegaard et al., 2012; Bar-El et al., 2016) . We demonstrated the importance of time-lapse microscopy for improving PGD outcomes and compared a subgroup of embryos that were biopsied at the 8-cell stage with a matched control group of non-biopsied embryos. The results showed the importance of analyzing this more homogenous group of 8-cell embryos, that is considered the optimal cell stage for biopsy since all blastomeres already completed their third cleavage and embryonic genome activation have already begun (Cimadomo et al., 2016) .
Although blastomere biopsy is still common in PGD, the exact timing of blastomere biopsy varies according to the timing of insemination/intracytoplasmic sperm injection (ICSI) and the schedule of each lab. The aim of this study was to evaluate the exact timing at which blastomere biopsy of 8-cell embryos will result in the best implantation potential and have the least harmful effect on further developing embryo.
Materials and Methods

Study population and design
All embryos in this study were fertilized by ICSI and cultured in the EmbryoScope™. The study group consisted of all embryos from women who underwent PGD treatment at our unit from September 2012 to June 2014 (317 cycles, 3865 embryos), that were at the 8-cell stage at the time of biopsy at 67-73 h following ICSI (mean = 70.4 ± 1.8 h), and cultured in the EmbryoScope™ until embryo transfer. Exclusion criteria included lowgrade embryos that were not suitable for blastomere biopsy (i.e. <6 cells or with >20% fragmentation). The final study group for all analyses included 195 biopsied embryos from 97 cycles. The indications for blastomere biopsy for PGD in the study group were monogenic diseases (63% of the cycles), chromosomal translocations (36% of the cycles) and sex selection for X-linked diseases with non-identified mutation (1% of the cycles).
The control group included all embryos from cycles performed during the same time period that underwent ICSI without biopsy, were cultured in the EmbryoScope™ until Day 5, had 8-blastomere (t8) < 70.4 h and 9-blastomere (t9) > 70.4 h, and had a recorded blastulation (69 cycles, 115 embryos). The indications for ICSI in the control group were male factor (71%), unexplained infertility (26%) and previous cycles of failed fertilization (3%).
Maternal age and body mass index (BMI) were similar in both groups. The number of mature oocytes and the resulting embryos (two pronucleate (2PN)) were also similar (P > 0.05). Taken together, these data demonstrate that the two groups were comparable in embryo development. Baseline and cycle characteristics are presented in Supplementary  Table S1 .
Ovarian stimulation, fertilization and embryo culture Controlled ovarian stimulation was carried out by the long gonadotropin releasing hormone (GnRH) agonist, the short GnRH agonist or GnRH antagonist protocols (Bar-El et al., 2016) . Choriogonadotropin alfa 250 mcg (Ovitrelle; Serono, Geneva, Switzerland) was administered when at least three follicles achieved an 18-mm diameter. Ovum pickup was performed 36 h later.
The cumulus-oocyte complexes were isolated into modified human tubal fluid (mHTF) (Irvine Scientific, California, USA). Sperm samples were treated with mHTF medium (Irvine Scientific), and insemination was performed by ICSI at 2-4 h following oocyte retrieval. Oocytes were denuded of cumulus cells by hyaluronidase and a fine pipette. ICSI was performed by means of a Nikon inverted microscope (Diaphot 300; Nikon, Japan) with Narishige micromanipulators. Each embryo was incubated in a separate droplet of human embryo culture medium covered with paraffin oil in an EmbryoSlide ® culture dish (Fertilitech, Denemark) to allow individual assessment and documentation. Incubation in the EmbryoScope™ incubator lasted from Day 1 following ICSI and continued up to Day 5 of development.
Blastomere biopsy for PGD
Blastomere biopsy for PGD was performed 67-73 h after ICSI. Prior to biopsy, the embryos were incubated for 2-5 min in Ca 2+ /Mg 2+ free medium (G-PGDw Vitrolife, Sweden) in order to loosen cell-to-cell adhesions. A~30 mm opening in the zona pellucida was performed by laser (Zilos™, Hamilton Thorne Research, MA, USA, wavelength 1480 nm), and one or two blastomeres were biopsied. After biopsy, the embryos were immediately returned to the EmbryoScope™ until transfer. The policy for blastomere biopsy in our unit is that one blastomere is biopsied for all genetic indications except for translocations or de novo monogenic mutations for which we prefer two blastomeres for the genetic analysis. A single blastomere is biopsied when only poorer quality embryos are available and the embryo has <7 cells.
Time-lapse monitoring of embryo morphokinetics
All embryos were incubated in the time-lapse monitoring system (EmbryoScope™; UnisenseFertiliTech A/S, Aarhus, Denmark, Vitrolyfe) from the time of ICSI until embryo transfer on Days 4-5. Embryo scoring and selection were performed by analysis of time-lapse images of each embryo with software developed specifically for image analysis (EmbryoViewer workstation; UnisenseFertilitech A/S). Embryo developmental events were recorded to demonstrate the precise timing of the observed cell divisions in correlation to the timing of ICSI: specifically, time of cleavage to a 2-blastomere (t2), 3-blastomere (t3) and so forth until reaching a 9-blastomere (t9) embryo. Timing of first signs of compaction (first time at which cell boundaries could no longer be clearly observed) were also recorded (t M ). The first signs of blastulation (t SB ) were recorded as soon as a star-shaped space was demonstrated in the compacted embryo, and the first sign of viability following biopsy was documented when the first cleavage after biopsy was observed (t FCAB ). Embryos that were transferred on Day 5 were annotated for t FCAB , t M and t SB , whereas embryos that were transferred on Day 4 were annotated solely for t FCAB and t M . All the assessments and annotations of the embryos were performed by senior embryologists, ensuring a very low interobserver variation.
Statistics
Maternal age and BMI were compared between cycles using a two-sample t-test and reported by means and standard deviations. Since the distribution of timing of cleavages was not normal in any of the developmental parameters, the Wilcoxon sum ranked test was used for comparisons between the study and control groups, Sidak's adjustment for multiple comparison was used. Data are presented as median and interquartile range (IQR; Q1, Q3). A P value of 0.05 was considered statistically significant. Statistical analysis was performed by SAS for Windows version 9.4 (Copyright (c) 2002-2012 by SAS Institute Inc., Cary, NC, USA).
Ethical approval
The study was approved by the ethics committee of Tel Aviv Medical Center, and institutional review board approval for retrieving IVF data was obtained (0748/15).
Results
In order to analyze how the timing of blastomere biopsy in relation to entry into the 8-cell stage affects its further development, the 8-cell stage was divided into four quarters: the first 5 h following t8 (Q1), at 5-10 h post-t8 (Q2), at 10-15 h post-t8 (Q3) and at 15-20 h post-t8 (Q4) (Fig. 1) . The non-biopsied 8-cell matched control group of embryos was divided into four equivalent quarters, and could therefore be expanded to include all non-biopsied ICSI embryos with t8 < 70.4 h and t9 > 70.4 h, resulting in 115 embryos (Fig. 1) .
Comparison of the pre-biopsy developmental events demonstrated similarity in timing between these two subgroups in most of the cleavage events (Supplementary Tables S2-S5 , P > 0.05). It is important to note that although some pre-biopsy parameters (t5 in Q2, and t2 and t3 in Q3) were different between the groups, the cleavage rate was comparable at the 8-cell stage when the blastomere biopsy took place, since there were no differences between the two groups at this stage (t8, P > 0.05 for all four quarters; Supplementary Tables S2-S5). It is, Figure 1 Schematic presentation of the 8-cell stage (from t8 to t9).
(A) Schematic presentation of the four quarters within the 8-cell stage (second cell cycle arrest) that were used to determine the optimal timing of blastomere biopsy. (B) Schematic diagram summarizing the study and control groups, including the distribution within the four quarters of the 8-cell stage. A total of 195 preimplantation genetic diagnosis (PGD) embryos and 115 intracytoplasmic sperm injection (ICSI) control embryos were divided into four quadrants according to the time of blastomere biopsy in relation to t8. therefore, reasonable to compare post-biopsy events between both groups.
We first analyzed the effect of blastomere biopsy on the timing of the first cleavage after biopsy (FCAB) compared to the control embryos (t9). The rationale for this comparison was that if the biopsy procedure itself has no effect on further developmental dynamics, then the timing of the FCAB should be similar to the timing of t9 in the non-biopsied group. Indeed, the results showed that the FCAB in embryos that were biopsied during Q1, Q2 or Q4 of the 8-cell stage occurred exactly at the same time as in the control group (P > 0.05). However, embryos that were biopsied during Q3 demonstrated a significant delay in development (P < 0.01) (Fig. 2) . In accordance, analysis of the timing of later developmental events, the timing of compaction (tM) and the timing of start of blastulation (tSB) demonstrated a significant delay only in embryos that were biopsied in Q3 (P < 0.01) (Fig. 3) .
In order to strengthen the above results on the effect of timing on further developmental events as well as on implantation potential, the study group was compared with a matched group of PGD embryos with verified implantation, i.e. embryos with Known Implantation Data, KIDpositive (PGD-KID+, n = 56). The PGD group (study group) also includes PGD-KID+ embryos. However, the PGD-KID+ embryos comprise only 4-10% of the total number of embryos in the study group. The numbers of PGD-KID+ embryos within each quarter were: Q1-2/50; Q2-1/53; Q3-6/61; Q4-3/31. The results showed that embryos biopsied during Q1, Q2 or Q3 of the 8-cell stage demonstrated a significant delay compared to the biopsied implanted embryos in t8 as well as in tM and tSB (P < 0.01) (Fig. 4) . However, fast-cleaving embryos that were biopsied during Q4 demonstrated similar dynamics to those of the biopsied implanted embryos in t8 and tM, with a delay having been observed only in tSB (P < 0.01) (Fig. 4) .
Discussion
We had previously shown that blastomere biopsy delays compaction and blastulation of embryos, leading to a decrease in implantation (Bar-El et al., 2016) . The current study analyzed, for the first time, the effect of the timing of blastomere biopsy during the 8-cell stage on the subsequent pre-and post-implantation embryonic development using TLM. Our results demonstrated that blastomere biopsy during Q4 had the least effect on further development compared to Q1, Q2 or Q3 of the 8-cell stage.
Since the beginning of IVF technology, selection for embryo transfer had relied on the assessment of its morphology. Embryos with the same morphology, however, were shown to sometimes have different kinetics that may also affect their potential for implantation. Embryo morphological evaluation is based on a single assessment at the same time every day. Time-lapse imaging was introduced into the routine IVF lab less than a decade ago (Pribenszky et al., 2010) . This showed that the kinetics of early preimplantation development is closely related to the embryo's potential to develop into blastocysts, as well as to its implantation potential and ultimately to birth rates (reviewed in Pribenszky et al., 2017) .
To date, there are still no guidelines for the optimal timing for biopsying 8-cell embryos for PGD. In most labs, blastomere biopsy is performed in the morning of Day 3 to allow enough time for the preimplantation genetic analysis. Due to the variability in embryo kinetics, different embryos reach the 8-cell stage at different time points following fertilization and are therefore biopsied at different time points in relation to their entry into the 8-cell stage. Human embryos are likely to remain at the 8-cell stage for a relatively long 'arrest phase' in which cells are preparing for the next cell cycle and embryonic genome activation takes place. The current study was specifically designed to determine the precise segment of the 8-cell stage that would represent the optimal timing for biopsy. Our results on PGD embryos revealed that a biopsy which is performed soon after t8 (at Q1, Q2) or late after t8 (Q4) has a minimal effect on further embryonic development, as compared to control embryos. It could be hypothesized that if blastomere biopsy is performed soon after it enters the 8-cell stage; the embryo has more time to overcome the impact of the procedure and adjust to the interference in its development. However, if the biopsy is performed towards the end of the 8-cell stage, the embryo has already been committed to the next cell division.
Living organisms are products of repeated rounds of cell growth and division. During this process, known as the 'cell cycle', a cell duplicates its DNA and then divides its contents evenly between the two resulting daughter cells. In eukaryotics, the cell cycle is a complex process that consists of a network of regulatory proteins, which dictates the progression of the cell through all stages. This system acts like a timer, which sets a fixed period for the cell to spend in each phase of the cell cycle (Elledge, 1996) . From the moment a fertilized egg starts to divide, the cells follow an exacting schedule that tells them when to divide, when to differentiate into a specialized cell, and when to assemble into emerging tissues, organs, and structures. Disrupted-timed responses can critically affect development (Gross, 2012) .
The Embryoscope TLM was introduced into our lab in 2012, since then, embryo kinetics is sequentially documented until embryo transfer or freezing. In addition, implantation is also documented for each embryo, providing the data on successful (KID+) and failed (KID−) implantation. Abnormal rates of cleavage (either too fast or too slow) might predict chromosomal abnormalities in embryos (Magli et al., 2007; Basile et al., 2014; Vera-Rodriguez et al., 2015) . Our results on the comparisons of the morphokinetics of all PGD embryos to that of implanted PGD embryos (PGD-KID+) showed that the fast-cleaving embryos that were biopsied during Q4 demonstrated the highest potential for implantation. Based on these results, we suggest that whenever several healthy embryos are available for transfer following blastomere biopsy, it is better to choose those that were biopsied during Q4, with the expectation that they will have the highest implantation potential.
Morphokinetic parameters were used to develop algorithms for scoring embryos according to their kinetics and in correlation to their implantation potential and the probability for resulting in a healthy live birth. We recently incorporated the KIDScore decision support tools for enhanced embryo evaluation (Vitrolife) to choose the embryos with the highest potential for implantation (Petersen et al., 2016) . The development of this algorithm was based on 3275 KID+ embryos that were annotated using TLM until Day 3. However, since an algorithm developed in a given clinic is not necessarily transferrable to another clinic, we continue to collect data of our KID+ embryos and use them in combination with the KIDScore™ model.
To summarize, these results suggest that growing embryos designated for blastomere biopsy in the setting of a TLM system may provide the embryologist with additional information to choose embryos with the best implantation potential after the PGD results have been obtained. The timing of cell division is very well controlled, and it usually follows a precise schedule that instructs them when to divide. Our findings showed that blastomere biopsy can be less harmful to further development if it is carried out during a critical period of embryonic growth. They also demonstrated the added value of TLM for determining the optimal timing for blastomere biopsy.
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